Cambridge Biotherapies™, a leader in advanced mental health treatments, proudly announces the introduction of Spravato™ (esketamine) nasal...
Treatment-Resistant Depression
Gilgamesh Pharmaceuticals, a clinical-stage neuroscience biotech developing best-in-class medicines to redefine mental healthcare, announces the successful completion...
Researchers at Fermata to Study SAINT Neuromodulation for Treatment-Resistant Major Depression
2 min read
Fermata, an outpatient psychiatric center of excellence, today announced a new clinical trial to study the SAINT™...
